Code |
Title |
–
|
Top Categories
|
3 |
Administration
|
3E |
Physiological Systems and Anatomical Regions
|
3E0
|
Introduction
Administration, Physiological Systems and Anatomical Regions, Introduction
|
3E0R |
Spinal Canal
|
3E0R0 |
Open
|
3E0R0A |
Stem Cells, Embryonic
|
3E0R0AZ
|
No Qualifier
Introduction of Embryonic Stem Cells into Spinal Canal, Open Approach
|
3E0R0E |
Stem Cells, Somatic
|
3E0R0E0
|
Autologous
Introduction of Autologous Somatic Stem Cells into Spinal Canal, Open Approach
|
3E0R0E1
|
Nonautologous
Introduction of Nonautologous Somatic Stem Cells into Spinal Canal, Open Approach
|
3E0R3 |
Percutaneous
|
3E0R30 |
Antineoplastic
|
3E0R302
|
High-dose Interleukin-2
Introduction of High-dose Interleukin-2 into Spinal Canal, Percutaneous Approach
|
3E0R303
|
Low-dose Interleukin-2
Introduction of Low-dose Interleukin-2 into Spinal Canal, Percutaneous Approach
|
3E0R304
|
Liquid Brachytherapy Radioisotope
Introduction of Liquid Brachytherapy Radioisotope into Spinal Canal, Percutaneous Approach
|
3E0R305
|
Other Antineoplastic
Introduction of Other Antineoplastic into Spinal Canal, Percutaneous Approach
|
3E0R30M
|
Monoclonal Antibody
Introduction of Antineoplastic, Monoclonal Antibody, into Spinal Canal, Percutaneous Approach
|
3E0R32 |
Anti-infective
|
3E0R328
|
Oxazolidinones
Introduction of Oxazolidinones into Spinal Canal, Percutaneous Approach
|
3E0R329
|
Other Anti-infective
Introduction of Other Anti-infective into Spinal Canal, Percutaneous Approach
|
3E0R33 |
Anti-inflammatory
|
3E0R33Z
|
No Qualifier
Introduction of Anti-inflammatory into Spinal Canal, Percutaneous Approach
|
3E0R36 |
Nutritional Substance
|
3E0R36Z
|
No Qualifier
Introduction of Nutritional Substance into Spinal Canal, Percutaneous Approach
|
3E0R37 |
Electrolytic and Water Balance Substance
|
3E0R37Z
|
No Qualifier
Introduction of Electrolytic and Water Balance Substance into Spinal Canal, Percutaneous Approach
|
3E0R3A |
Stem Cells, Embryonic
|
3E0R3AZ
|
No Qualifier
Introduction of Embryonic Stem Cells into Spinal Canal, Percutaneous Approach
|
3E0R3B |
Anesthetic Agent
|
3E0R3BZ
|
No Qualifier
Introduction of Anesthetic Agent into Spinal Canal, Percutaneous Approach
|
3E0R3E |
Stem Cells, Somatic
|
3E0R3E0
|
Autologous
Introduction of Autologous Somatic Stem Cells into Spinal Canal, Percutaneous Approach
|
3E0R3E1
|
Nonautologous
Introduction of Nonautologous Somatic Stem Cells into Spinal Canal, Percutaneous Approach
|
3E0R3G |
Other Therapeutic Substance
|
3E0R3GC
|
Other Substance
Introduction of Other Therapeutic Substance into Spinal Canal, Percutaneous Approach
|
3E0R3H |
Radioactive Substance
|
3E0R3HZ
|
No Qualifier
Introduction of Radioactive Substance into Spinal Canal, Percutaneous Approach
|
3E0R3K |
Other Diagnostic Substance
|
3E0R3KZ
|
No Qualifier
Introduction of Other Diagnostic Substance into Spinal Canal, Percutaneous Approach
|
3E0R3N |
Analgesics, Hypnotics, Sedatives
|
3E0R3NZ
|
No Qualifier
Introduction of Analgesics, Hypnotics, Sedatives into Spinal Canal, Percutaneous Approach
|
3E0R3S |
Gas
|
3E0R3SF
|
Other Gas
Introduction of Other Gas into Spinal Canal, Percutaneous Approach
|
3E0R3T |
Destructive Agent
|
3E0R3TZ
|
No Qualifier
Introduction of Destructive Agent into Spinal Canal, Percutaneous Approach
|
3E0R7 |
Via Natural or Artificial Opening
|
3E0R7S |
Gas
|
3E0R7SF
|
Other Gas
Introduction of Other Gas into Spinal Canal, Via Natural or Artificial Opening
|